简体中文|English
Trial search Nation, Province(City) Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Recruiting status Register status Measure Ethical committee Study type
Funding source in Global project
Year：

self-funded

Check the details 127(4.68%)

none

Check the details 110(4.06%)

Self-financing

Check the details 90(3.32%)

self-raised

Check the details 78(2.88%)

self-funding

Check the details 23(0.85%)

No

Check the details 22(0.81%)

Sponsor

Check the details 22(0.81%)

The Second Hospital of Shanxi Medical University

Check the details 19(0.70%)

self-finance

Check the details 19(0.70%)

raise independently

Check the details 16(0.59%)

Self financing

Check the details 15(0.55%)

self-raised funds

Check the details 15(0.55%)

National Natural Science Foundation of China

Check the details 15(0.55%)

self-financed

Check the details 14(0.52%)

Self-selected topic (self-funded)

Check the details 13(0.48%)

National Natural Science Foundation of China

Check the details 12(0.44%)

Ministry of Finance of China

Check the details 9(0.33%)

NA

Check the details 9(0.33%)

No Funding

Check the details 7(0.26%)

The Second Hospital of Shanxi Medical University

Check the details 7(0.26%)

Self-selected project (self-funded)

Check the details 6(0.22%)

Ministry of Science and Technology, China

Check the details 6(0.22%)

Self-raising

Check the details 6(0.22%)

Self support

Check the details 6(0.22%)

Project funding

Check the details 6(0.22%)

Beijing Medical Award Foundation

Check the details 6(0.22%)

Foundations and self-financing

Check the details 6(0.22%)

enterprise

Check the details 5(0.18%)

Research Funding

Check the details 5(0.18%)

self-fund

Check the details 5(0.18%)

self-raised fund

Check the details 4(0.15%)

Self selected topic (self funded)

Check the details 4(0.15%)

Qyuns Therapeutics Co., Ltd.

Check the details 4(0.15%)

Provided by the sponsor

Check the details 4(0.15%)

Qilu Pharmaceutical Co., Ltd.

Check the details 4(0.15%)

Sanofi (Beijing) Pharmaceutical Co., Ltd.

Check the details 4(0.15%)

National Natural Science Foundation of China

Check the details 4(0.15%)

National Science and Technology Major Project

Check the details 4(0.15%)

National Key Research and Development Program of China

Check the details 4(0.15%)

National Administration of Traditional Chinese Medicine

Check the details 4(0.15%)

Health industry funding for research and special projects

Check the details 4(0.15%)

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Check the details 4(0.15%)

The key project of the national key research and development plan

Check the details 4(0.15%)

The First Hospital of Shanxi Medical University

Check the details 4(0.15%)

self-raised

Check the details 3(0.11%)

sponser

Check the details 3(0.11%)

State Administration of Traditional Chinese Medicine of the People's Republic of China

Check the details 3(0.11%)

Self-selected topic

Check the details 3(0.11%)

Shanxi clinical research center of traditional Chinese medicine

Check the details 3(0.11%)

Shenzhen Ruipuxun Academy for Stem Cell & Regenerative Medicine

Check the details 3(0.11%)

Special Research Fund for Central Universities, Peking Union Medical College (332021099); Beijing Hope Run Special Fund of Cancer Foundation of China (LC2021A18)

Check the details 3(0.11%)

Wu Jieping medical foundation

Check the details 3(0.11%)

Jiangsu Hengrui Medicine Co., Ltd.

Check the details 3(0.11%)

Enterprise funding

Check the details 3(0.11%)

Chinese Anti-Cancer Association- HengRui pharmaceutical innovative medicine clinical research fund

Check the details 3(0.11%)

Corporate Sponsorship

Check the details 3(0.11%)

First Hospital of Shanxi Medical University

Check the details 3(0.11%)

Fully self-funded

Check the details 3(0.11%)

Fully self-raised

Check the details 3(0.11%)

Funds raised by oneself

Check the details 3(0.11%)

Bloomage Biotechnology Corporation Limited

Check the details 3(0.11%)

Bethune Charitable Foundation

Check the details 3(0.11%)

136 Xingyi project

Check the details 3(0.11%)

APT Medical Inc.

Check the details 3(0.11%)

Beijing Kangmeng Charity Foundation

Check the details 3(0.11%)

National key research and development program

Check the details 3(0.11%)

National Key Research and Development Program of China "Clinical cure and related mechanisms of chronic hepatitis B in infants, children and adults aged 1-12"

Check the details 3(0.11%)

Ministry of Science and Technology of the People's Republic of China

Check the details 3(0.11%)

National Key R&D Program of China

Check the details 3(0.11%)

Nil

Check the details 3(0.11%)

National Natural Science Foundation of China

Check the details 3(0.11%)

Non

Check the details 3(0.11%)

Optional project

Check the details 3(0.11%)

National

Check the details 3(0.11%)

National Basic Research Program of China (973 Program)

Check the details 3(0.11%)

Jiangsu Hengrui Pharmaceutical Co., LTD

Check the details 3(0.11%)

Science and Technology Innovation Project of China Academy of Chinese Medical Sciences

Check the details 3(0.11%)

Self funded

Check the details 3(0.11%)

Sanofi (China) Investment Co., Ltd. Shanghai Branch

Check the details 3(0.11%)

Self funding

Check the details 3(0.11%)

self raised

Check the details 3(0.11%)

Public health vocation scientific research fund project

Check the details 3(0.11%)

N/A

Check the details 3(0.11%)

Not applicable

Check the details 3(0.11%)

Project funded by Shanxi Provincial Key Laboratory for major infectious disease response; COVID-19 project funded by Shanxi Provincial Finance

Check the details 3(0.11%)

self-prepare capital

Check the details 3(0.11%)

Self-financing fund

Check the details 3(0.11%)

self-raise

Check the details 2(0.07%)

Self selected topic (self raised)

Check the details 2(0.07%)

Self selected topic

Check the details 2(0.07%)

self-finacing

Check the details 2(0.07%)

Self-financed by enterprises

Check the details 2(0.07%)

self-collected

Check the details 2(0.07%)

Shandong Huaxin Pharmaceutical Group Co. LTD

Check the details 2(0.07%)

Shanghai EnnovaBio Pharmaceuticals Co., Ltd

Check the details 2(0.07%)

Shanghai Lebangda Pharmaceutical Technology Co., Ltd.

Check the details 2(0.07%)

Shanghai Ke Qi pharmaceutical technology Co., Ltd.

Check the details 2(0.07%)

Shanxi Bethune Hospital

Check the details 2(0.07%)

Postdoctoral Research Fund

Check the details 2(0.07%)

Postdoctoral Scientific Research Developmental Fund of Heilongjiang Province (LBH-Q21180)

Check the details 2(0.07%)
欢迎访问WHO国际临床试验注册平台 Clinical Trials Hong Kong

Chinese Clinical Trial Registry, Primary Registry of WHO International Clinical Trials Registry Platform

Copyright(c) (2005 - 2023) Chictr.org.cn.All rights reserved. Chinese Clinical Trial Registry

蜀ICP备16010396号-9

Note: It is recommended to use the widescreen display resolution of Internet Explorer 8.0 or later